Organigram Global Inc. Common Shares
OGIUnited States
1 filed reports · 221 financial concepts · 4 earnings calls · 0 media appearances
Filed reports
1 reports · Sep 2025Each report counts once it has at least one extracted financial fact.
| Report type | Reports | Facts | Periods |
|---|---|---|---|
| Annual · 40-FSEC EDGAR | 1 | 567 | Sep 2025 |
Documents
| Period | Type | Period end | Published | Facts | Source |
|---|---|---|---|---|---|
| FY2025 | 40-F | Sep 30, 2025 | Dec 16, 2025 | 567 | Open |
Financial data
221 concepts · 567 factsEach concept is one reported line item or metric. The count is how many values of it are held, across the periods shown.
Financial220 concepts · 557 facts · Sep 2024 to Sep 2025
- Set-off of tax8 · Sep 2024 to Sep 2025
- Number of outstanding share options6 · Sep 2024 to Sep 2025
- Accumulated other comprehensive income4 · Sep 2024 to Sep 2025
- Assets (IFRS)4 · Sep 2024 to Sep 2025
- Average selling price per gram (excluding trim) (in CAD per gram)4 · Sep 2024 to Sep 2025
- Capital consideration4 · Sep 2024 to Sep 2025
- Capital expenditures related to joint operations4 · Sep 2024 to Sep 2025
- Cash and cash equivalents4 · Sep 2024 to Sep 2025
- Cash (IFRS)4 · Sep 2024 to Sep 2025
- Current assets4 · Sep 2024 to Sep 2025
- Current biological assets4 · Sep 2024 to Sep 2025
- Current contingent consideration4 · Sep 2024 to Sep 2025
- Current Deferred Consideration4 · Sep 2024 to Sep 2025
- Current derivative financial liabilities (IFRS)4 · Sep 2024 to Sep 2025
- Current finance lease receivables4 · Sep 2024 to Sep 2025
- Current lease liabilities (IFRS)4 · Sep 2024 to Sep 2025
- Current liabilities4 · Sep 2024 to Sep 2025
- Current packaging and storage materials4 · Sep 2024 to Sep 2025
- Current portion of longterm borrowings4 · Sep 2024 to Sep 2025
- Current prepayments and other current assets4 · Sep 2024 to Sep 2025
- Current restricted cash and cash equivalents4 · Sep 2024 to Sep 2025
- Current value added tax receivables4 · Sep 2024 to Sep 2025
- Deductible temporary differences for which no deferred tax asset is recognised4 · Sep 2024 to Sep 2025
- Deferred charges and deposits4 · Sep 2024 to Sep 2025
Product1 concepts · 10 facts · Sep 2024 to Sep 2025
- Gross revenue (Note 20)10 · Sep 2024 to Sep 2025
Segments
10 factsFigures broken down by business line, region, product or another axis the company reports on.
Products and services5 members · 10 facts
- Direct To Patient Medical Revenue2 · Sep 2024 to Sep 2025
- International Business To Business2 · Sep 2024 to Sep 2025
- Other Revenue2 · Sep 2024 to Sep 2025
- Recreational Wholesale Revenue2 · Sep 2024 to Sep 2025
- Wholesale To Licensed Producers Revenue2 · Sep 2024 to Sep 2025
Text from filings
Management commentary and risk factors, extracted from SEC filings only.
No commentary or risk-factor text for this company.
Earnings calls
4 calls · Aug 2025 to Aug 2026Transcripts with management claims and analyst questions, one per fiscal period.
- FY2026 Q3Aug 11, 2026
- FY2026 Q1Feb 10, 2026
- FY2025 Q4Dec 16, 2025
- FY2025 Q3Aug 13, 2025
Executive media
Podcasts, interviews and conference appearances by the company's executives, with their claims.
No media appearances for this company.
Reports are counted as filed reports with at least one served fact. Counts are read from the database (last read Oct 16, 2026) and refreshed every few hours.